Baidu
map

预防性使用质子泵抑制剂及处方精简专家指导意见

2019-07-01 广东省药学会 广东省药学会官网

质子泵抑制剂(proton pump inhibitor,PPI)通过抑制胃壁细胞上的H+/K+-ATP酶,强而持久地抑制胃酸分泌,目前PPI广泛用于治疗胃食管反流病、消化性溃疡、幽门螺杆菌感染、上消化道出血、卓-艾综合征等酸相关性疾病。 目前PPI的不合理使用主要表现在预防性用药指征不明确和预防疗程过长。为此,广东省药学会组织药学及临床专家特制定本指导意见,为规范临床预防性使用PPI提供参考

中文标题:

预防性使用质子泵抑制剂及处方精简专家指导意见

发布机构:

广东省药学会

发布日期:

2019-07-01

简要介绍:

质子泵抑制剂(proton pump inhibitor,PPI)通过抑制胃壁细胞上的H+/K+-ATP酶,强而持久地抑制胃酸分泌,目前PPI广泛用于治疗胃食管反流病、消化性溃疡、幽门螺杆菌感染、上消化道出血、卓-艾综合征等酸相关性疾病。 目前PPI的不合理使用主要表现在预防性用药指征不明确和预防疗程过长。为此,广东省药学会组织药学及临床专家特制定本指导意见,为规范临床预防性使用PPI提供参考

拓展指南:质子泵抑制剂相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=预防性使用质子泵抑制剂及处方精简专家指导意见)] GetToolGuiderByIdResponse(projectId=1, id=2450f1c001e586c5, title=预防性使用质子泵抑制剂及处方精简专家指导意见, enTitle=, guiderFrom=广东省药学会官网, authorId=null, author=, summary=质子泵抑制剂(proton pump inhibitor,PPI)通过抑制胃壁细胞上的H+/K+-ATP酶,强而持久地抑制胃酸分泌,目前PPI广泛用于治疗胃食管反流病、消化性溃疡、幽门螺杆菌感染、上消化道出血、卓-艾综合征等酸相关性疾病。 目前PPI的不合理使用主要表现在预防性用药指征不明确和预防疗程过长。为此,广东省药学会组织药学及临床专家特制定本指导意见,为规范临床预防性使用PPI提供参考 , cover=, journalId=null, articlesId=null, associationId=1082, associationName=广东省药学会, associationIntro=广东省药学会前身为1945年成立的广州药师公会,1951年成为中国药学会广州分会。1958年在原有基础上扩大组织,成立中国药学会广东分会,负责组织全省药学科技工作者的相关活动。1985年起,中国药学会广东分会一直挂靠在广东省食品药品监督管理局(省医药管理局)。1991年,按民政部门文件要求更名为广东省药学会。, copyright=0, guiderPublishedTime=Mon Jul 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>质子泵抑制剂(proton pump inhibitor,PPI)通过抑制胃壁细胞上的H+/K+-ATP酶,强而持久地抑制胃酸分泌,目前PPI广泛用于治疗胃食管反流病、消化性溃疡、幽门螺杆菌感染、上消化道出血、卓-艾综合征等酸相关性疾病。 目前PPI的不合理使用主要表现在预防性用药指征不明确和预防疗程过长。为此,广东省药学会组织药学及临床专家特制定本指导意见,为规范临床预防性使用PPI提供参考</div> <div><br> </div>拓展指南:<strong>与<font color=red>质子泵抑制剂</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=32a151c0016980bb" title="质子泵抑制剂预防性应用专家共识(2018)" target=_blank>质子泵抑制剂预防性应用专家共识(2018)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=3ef4f1c001a513e9" title="2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益" target=_blank>2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=509601c001a34086" title="2017 循证临床实践指南:质子泵抑制剂处方精简" target=_blank>2017 循证临床实践指南:质子泵抑制剂处方精简</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=605b81c0013e9ac5" title="2017 非处方质子泵抑制剂安全合理使用共识" target=_blank>2017 非处方质子泵抑制剂安全合理使用共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=21e841c001268949" title="2016 湖南省质子泵抑制剂的临床应用指导原则(试行)" target=_blank>2016 湖南省质子泵抑制剂的临床应用指导原则(试行)</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%B4%A8%E5%AD%90%E6%B3%B5%E6%8A%91%E5%88%B6%E5%89%82" target=_blank>有关质子泵抑制剂更多指南</a></ul>, tagList=[TagDto(tagId=1835, tagName=质子泵抑制剂), TagDto(tagId=69092, tagName=处方精简)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16229, appHits=477, showAppHits=6, pcHits=13493, showPcHits=3435, likes=91, shares=15, comments=4, approvalStatus=1, publishedTime=Mon Jul 08 23:05:43 CST 2019, publishedTimeString=2019-07-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jul 08 23:05:43 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 01:20:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=预防性使用质子泵抑制剂及处方精简专家指导意见)])
预防性使用质子泵抑制剂及处方精简专家指导意见
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193398, encodeId=9c311193398fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9fa5268635, createdName=14819fe3m35暂无昵称, createdTime=Mon Feb 14 20:35:11 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914638, encodeId=b29091463866, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210108/5dfc2866376c424b865e56a1e638c00b/086417caeb184ac0b968d8655dbf5741.jpg, createdBy=6bed5450750, createdName=ms7000000488748710, createdTime=Fri Jan 08 14:51:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902817, encodeId=2ac690281e0d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:02:47 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2022-02-14 14819fe3m35暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193398, encodeId=9c311193398fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9fa5268635, createdName=14819fe3m35暂无昵称, createdTime=Mon Feb 14 20:35:11 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914638, encodeId=b29091463866, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210108/5dfc2866376c424b865e56a1e638c00b/086417caeb184ac0b968d8655dbf5741.jpg, createdBy=6bed5450750, createdName=ms7000000488748710, createdTime=Fri Jan 08 14:51:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902817, encodeId=2ac690281e0d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:02:47 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-01-08 ms7000000488748710

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193398, encodeId=9c311193398fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9fa5268635, createdName=14819fe3m35暂无昵称, createdTime=Mon Feb 14 20:35:11 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914638, encodeId=b29091463866, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210108/5dfc2866376c424b865e56a1e638c00b/086417caeb184ac0b968d8655dbf5741.jpg, createdBy=6bed5450750, createdName=ms7000000488748710, createdTime=Fri Jan 08 14:51:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902817, encodeId=2ac690281e0d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:02:47 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 公冶花

    学习

    0

Baidu
map
Baidu
map
Baidu
map